Navigation Links
Though pharma growth slides, blockbusters reach new record

The global pharmaceutical market failed to reach double-digit growth in 2004 for the first time in about nine years. Key reasons for this focused on concerns over drug safety, pricing and competition from generic drugs as major products had their patents expire.

Let's take a look at how the market did. This is according to the estimates of IMS Health, a phar......

Full article >>>
'"/>

Source:wistechnology.com By Michael Rosen 06/06/05


Page: 1 2 3

Related biology technology :

1. Though Weakening, Biotech IPO Market Still Viable, Burril & Co. Says
2. Though VC investing is down, reloading on new funds is rising
3. Development of a sensitive enzyme fragment complementation assay for cyclic adenosine 3, 5 monophosphate and its validation for pharmacological screening at G protein-coupled receptors
4. Germantown drug company hires pharma veteran James Davidson as COO
5. New angel capital centered on GenTel agreement with big pharma
6. Big pharma seeks Wisconsin biotech partnerships
7. Doing the pharmaceutical tango
8. Chinese pharma-biotech dragon rears its head
9. Swiss biotech has quality of its big pharma, watch and chocolate industries
10. Third Wave receives FDA clearance of pharmacogenetic test
11. Line between big pharma, big biotech continues to blur

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Though pharma growth slides blockbusters reach new record

(Date:11/5/2009)...d., Nov. 5 GenVec, Inc. ...ults for the third quarter ended September 30, 200...04 per share) for the three months ended September...$0.08 per share) in the comparable quarter of 2008...nVec,s net loss was $14.1 million ($0.15 per share...
(Date:11/5/2009)... 5 Imagenetix, Inc. (OTC...am Spencer, President and CEO of Imagenetix, will ...l LD MICRO Conference on Thursday, December 3rd, a...,, About LD MICRO ,, LD MICRO is a by-invita...undervalued companies in the micro-cap space. Sinc...
(Date:11/5/2009)...v. 5 Transgenomic, Inc. ...al results for the quarter ended September 30, 200...n the tables that follow. ,, Third Quarter 200...00 or $0.01 per share for the third quarter of 200...er share for the third quarter of 2008. ,, Net...
(Date:11/5/2009)...as, Nov. 5 Wound Managem...at it has entered into a Letter of Intent to purch...h Technologies, Inc. (OTC Bulletin Board: VHGI). T... cash and debt, 4,000,000 shares of WNDM and a roy...he Veriscrip technology being acquired from VHGI. ...
Breaking Biology Technology:GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 2Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 2OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 3
...tober 27 Stallergenes has,just obtained authoriza...ng,a phase III clinical trial in the United States...gic rhinoconjunctivitis to grass pollens in adults...in 450 American patients,during the 2009 pollen se...e of the product in adults and to support the appl...
...Oct. 27 Dr. Annie De Groot, CEO of,EpiVax, is the...gs about,the activation of natural regulatory T ce... or "Tregitopes." These findings were published in... medical journal published by,the American Society...chel Caspi of the National Institutes,of Health (N...
... Edmontonians magazine is partnering with ...chnology community and its companies and prove how...ct businesses. , Edmonton...onthly business publication serving the Capital Re...t, Innovation, Ingenuity project with the goal of...
Other Biology Technology:Stallergenes: Launch of a Phase III Clinical Trial in Adults for Oralair(R) Grasses in the United States Operating Income Expected to Remain Stable in 2009 2Stallergenes: Launch of a Phase III Clinical Trial in Adults for Oralair(R) Grasses in the United States Operating Income Expected to Remain Stable in 2009 3Publication on 'Tregitopes' in Blood Journal of October 2008 2Edmonton's Technology Community: Using Social Media to Raise Awareness 2
(Date:11/4/2009)...eavy traffic corridors in the cities of Long Beach...roportion of preventable childhood asthma, and the...n the disease has likely been underestimated, acco... California (USC). , The study, which appears i...blic Health , estimated that nine percent of all c...
(Date:11/4/2009)...ancouver, BC - Lowly bacteria, it turns out, hold ...turing plants around the world clean up toxic wast..., specifically RDX, were invented back in World Wa...decades. These high-energy compounds are often us...ful version of TNT. , But with increased knowl...
(Date:11/4/2009)...he University of Oklahoma at Norman has received m...funding agencies as part of the federal stimulus p...ng received by OU researchers to $23 million. Thi...search ranging from archaeology to weather. , "T...atic approach to matching areasof scholarly excell...
Breaking Biology News(10 mins):USC study finds big air pollution impacts on local communities 2Genomic research will enable greener cleanup of military explosive test sites 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 3New Medical Imaging Organization Launched to Represent Industry Personnel and Diagnostic Clinics 51599 1New Medical Imaging Organization Launched to Represent Industry Personnel and Diagnostic Clinics 51599 2Inspiration Biopharmaceuticals Presents Safety Data on IB1001 a Novel Recombinant Factor IX for the Treatment of Hemophilia at the International Soci 13015 1Inspiration Biopharmaceuticals Presents Safety Data on IB1001 a Novel Recombinant Factor IX for the Treatment of Hemophilia at the International Soci 13015 2JBFCS Surpasses Fundraising Goal For Hudson Valley Bike Ride Despite Difficult Financial Times 51594 1JBFCS Surpasses Fundraising Goal For Hudson Valley Bike Ride Despite Difficult Financial Times 51594 2
...a Tech researchers in computer science and biology...X, to create models and algorithms that make it po... leading to cell division. They have demonstrated ...orithms provide powerful tools for studying the co...ologist John Tyson, who studies the cell cycle, is...
...ity of Newcastle researcher Kathryn Skelding, fund...ralytics Ltd, has been working on a new treatment ...improvement on conventional chemotherapy and radia...ells. , "In theory, the virus is able to selective...er cells, including breast cancers, whilst leaving...
...ent, chronic pain has risen dramatically among ful...ers today opt to go to their jobs rather than call...sm ?a negative impact on work despite being physic...y, are from a 2006 national survey conducted by Ha....painandwork.com ), sponsored by PriCaraÔ, Unit of...
Other Biology News:Virginia Tech's System X supercomputer provides super tool for simulation of cell division 2Virginia Tech's System X supercomputer provides super tool for simulation of cell division 3Common cold virus may kill breast cancer cells 2Chronic pain up almost 40 percent among US workers in past decade 2
Rabbit Anti-ZNF261 Polyclonal Antibody, Unconjugated from Abcam
Psp1406 I from Takara Mirus Bio
Mouse Anti-Integrin alpha M Monoclonal Antibody, Unconjugated, Clone ICRF 44 from Novus Biologicals
Rabbit Anti-CKB, N-Terminus Polyclonal Antibody, Unconjugated from Abgent
Biology Products: